HCPCS Level II
J9211
Injection, idarubicin hydrochloride, 5 mg
Codes near J9211
These sit next to J9211 in the CMS Level II file. All J codes
- J9206Injection, irinotecan, 20 mg
- J9207Injection, ixabepilone, 1 mg
- J9208Injection, ifosfamide, 1 gram
- J9209Injection, mesna, 200 mg
- J9210Injection, emapalumab-lzsg, 1 mg
- J9212Injection, interferon alfacon-1, recombinant, 1 microgram
- J9213Injection, interferon, alfa-2a, recombinant, 3 million units
- J9214Injection, interferon, alfa-2b, recombinant, 1 million units
- J9215Injection, interferon, alfa-n3, (human leukocyte derived), 250, 000 iu
- J9216Injection, interferon, gamma 1-b, 3 million units
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00013-2576-05 | Idamycin Pfs | Pfizer Inc | 1 |
| 00013-2576-91 | Idamycin Pfs | Pfizer Inc | 1 |
| 00013-2586-10 | Idamycin Pfs | Pfizer Inc | 2 |
| 00013-2586-91 | Idamycin Pfs | Pfizer Inc | 2 |
| 00013-2596-20 | Idamycin Pfs | Pfizer Inc | 4 |
| 00013-2596-91 | Idamycin Pfs | Pfizer Inc | 4 |
| 00143-9217-01 | Idarubicin | Hikma Pharmaceuticals USA Inc. | 1 |
| 00143-9218-01 | Idarubicin | Hikma Pharmaceuticals USA Inc. | 2 |
| 00143-9219-01 | Idarubicin | Hikma Pharmaceuticals USA Inc. | 4 |
| 00143-9306-01 | Idarubicin | Hikma Pharmaceuticals USA Inc. | 1 |
| 00143-9307-01 | Idarubicin | Hikma Pharmaceuticals USA Inc. | 2 |
| 00143-9308-01 | Idarubicin | Hikma Pharmaceuticals USA Inc. | 4 |
| 71288-0184-05 | Idarubicin HCl | Meitheal Pharmaceuticals Inc. | 1 |
| 71288-0185-10 | Idarubicin HCl | Meitheal Pharmaceuticals Inc. | 2 |
| 71288-0186-20 | Idarubicin HCl | Meitheal Pharmaceuticals Inc. | 4 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.